On May 10, 2023, Atreca (NASDAQ:BCEL) announced its financial results for the first quarter of the year. The company reported a quarterly loss of $(0.54) per share, which exceeded the analyst consensus estimate of $(0.56) by 3.57 percent. This marks a 16.92 percent increase over the losses of $(0.65) per share from the same period in 2022.
In addition to this, Atreca also revealed its financial results for the first quarter of 2022, which showed a net loss per share of $0.78. The company’s earnings history demonstrates that it has experienced losses in the past few quarters, with a net loss per share of $0.60 in the third quarter of 2022 and $0.72 in the second quarter of 2022.
While Atreca has not confirmed its next earnings publication date, it is estimated to be on Wednesday, May 10th, 2023, based on last year’s report dates.
BCEL Stock Update: May 10, 2023 – Earnings Growth, Revenue Growth, and Trading Volume
On May 10, 2023, BCEL stock opened at 1.13, higher than its previous close of 1.10, with a day’s range between 1.10 and 1.14 and a volume of 1,784 shares traded. BCEL’s earnings growth rate was 14.71% in the last year and 22.44% this year, with no data available for the earnings growth rate for the next five years. The revenue growth rate for the last year was -9.52%. The P/E ratio for BCEL was not available, but the price/sales ratio was 40.13, and the price/book ratio was 0.50. Medivir AB and FSI showed no change and a 0.35% increase, respectively, while TARA showed a significant increase of 6.75%. BCEL’s next reporting date was May 11, 2023, with an EPS forecast of -$0.57 for this quarter. BCEL’s annual revenue for the last year was $770.0K, and the annual profit was -$97.2M, resulting in a net profit margin of -12,617.79%. BCEL operates in the health technology sector and has its corporate headquarters in San Carlos, California.
BCEL Stock Soars Due to Positive News on Atreca Inc: What Investors Need to Know
On May 10th, 2023, BCEL stock experienced a significant increase in value due to positive news regarding Atreca Inc, a company in which BCEL has a stake. According to data from CNN Money, the eight analysts offering 12-month price forecasts for Atreca Inc have a median target of 8.00, with a high estimate of 25.00 and a low estimate of 1.50. This represents a +614.29% increase from the last price of 1.12.
The current consensus among nine polled investment analysts is to buy stock in Atreca Inc, a rating that has held steady since March, when it was unchanged from a buy rating. This positive sentiment towards Atreca Inc has likely contributed to the increase in BCEL stock value.
Moving on to BCEL’s financial performance, the current quarter’s earnings per share stand at -$0.57, with sales at $0.00. This indicates that the company is currently operating at a loss. However, it is important to note that BCEL’s stake in Atreca Inc could potentially offset these losses in the long run, especially if Atreca Inc’s stock continues to perform well.
Looking ahead, BCEL is set to report its earnings on May 11th, 2023. It will be interesting to see how the company’s financial performance compares to the positive news surrounding Atreca Inc. Investors will likely be paying close attention to any updates on BCEL’s stake in Atreca Inc and how it is expected to impact the company’s future financial performance.
Overall, BCEL’s stock performance on May 10th, 2023 was largely driven by positive news surrounding Atreca Inc. While BCEL is currently operating at a loss, its stake in Atreca Inc could potentially offset these losses in the long run. Investors will be closely monitoring BCEL’s upcoming earnings report for any updates on the company’s financial performance and its stake in Atreca Inc.